...
gnta-img

Genenta Science SpA ADR, Common Stock

GNTA

NAQ

$4.8971

-$0.11

(-2.2%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$91.63M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
13.22K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.74
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.2 L
$7.28 H
$4.8971

About Genenta Science SpA ADR, Common Stock

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameGNTASectorS&P500
1-Week Return-7.6%-0.94%-2.6%
1-Month Return2.24%-5.08%-1.08%
3-Month Return32.35%-10.62%3.45%
6-Month Return46.62%-6.18%8.57%
1-Year Return-3.9%1.98%24.3%
3-Year Return-58.67%-0.93%25.58%
5-Year Return-55.48%33.84%84.07%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue-1.77K5.08K6.03K41.58K[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":4.26,"profit":true},{"date":"2021-12-31","value":12.23,"profit":true},{"date":"2022-12-31","value":14.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit-(1.77K)(5.08K)(6.03K)(41.58K)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-177022,"profit":false},{"date":"2021-12-31","value":-508402,"profit":false},{"date":"2022-12-31","value":-602942,"profit":false},{"date":"2023-12-31","value":-4158200,"profit":false}]
Gross Margin-(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses4.62M5.59M5.54M11.04M11.73M[{"date":"2019-12-31","value":39.41,"profit":true},{"date":"2020-12-31","value":47.65,"profit":true},{"date":"2021-12-31","value":47.19,"profit":true},{"date":"2022-12-31","value":94.13,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(4.62M)(5.59M)(5.69M)(11.04M)(11.73M)[{"date":"2019-12-31","value":-462450200,"profit":false},{"date":"2020-12-31","value":-559022600,"profit":false},{"date":"2021-12-31","value":-568727300,"profit":false},{"date":"2022-12-31","value":-1104399200,"profit":false},{"date":"2023-12-31","value":-1173294200,"profit":false}]
Total Non-Operating Income/Expense17.23K(9.54K)146.22K2.60M396.74K[{"date":"2019-12-31","value":0.66,"profit":true},{"date":"2020-12-31","value":-0.37,"profit":false},{"date":"2021-12-31","value":5.62,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":15.24,"profit":true}]
Pre-Tax Income(4.60M)(5.59M)(5.53M)(8.48M)(11.65M)[{"date":"2019-12-31","value":-459772300,"profit":false},{"date":"2020-12-31","value":-559201400,"profit":false},{"date":"2021-12-31","value":-552933200,"profit":false},{"date":"2022-12-31","value":-847776300,"profit":false},{"date":"2023-12-31","value":-1164545500,"profit":false}]
Income Taxes9.55K13.72K31.37K(4.85M)4.00[{"date":"2019-12-31","value":30.45,"profit":true},{"date":"2020-12-31","value":43.73,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-15468.46,"profit":false},{"date":"2023-12-31","value":0.01,"profit":true}]
Income After Taxes(4.61M)(5.61M)(5.56M)(3.62M)(11.65M)[{"date":"2019-12-31","value":-460727500,"profit":false},{"date":"2020-12-31","value":-560573400,"profit":false},{"date":"2021-12-31","value":-556070500,"profit":false},{"date":"2022-12-31","value":-362484400,"profit":false},{"date":"2023-12-31","value":-1164545900,"profit":false}]
Income From Continuous Operations(4.60M)(5.59M)(5.53M)(8.48M)(11.65M)[{"date":"2019-12-31","value":-459772300,"profit":false},{"date":"2020-12-31","value":-559201400,"profit":false},{"date":"2021-12-31","value":-552933200,"profit":false},{"date":"2022-12-31","value":-847776300,"profit":false},{"date":"2023-12-31","value":-1164545500,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(4.61M)(5.61M)(5.56M)(3.62M)(11.65M)[{"date":"2019-12-31","value":-460727500,"profit":false},{"date":"2020-12-31","value":-560573400,"profit":false},{"date":"2021-12-31","value":-556070500,"profit":false},{"date":"2022-12-31","value":-362484400,"profit":false},{"date":"2023-12-31","value":-1164545500,"profit":false}]
EPS (Diluted)(0.09)(0.51)---[{"date":"2019-12-31","value":-9.47,"profit":false},{"date":"2020-12-31","value":-51.14,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

GNTA
Cash Ratio 10.82
Current Ratio 12.25
Quick Ratio 12.25

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GNTA
ROA (LTM) -25.83%
ROE (LTM) -42.89%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GNTA
Debt Ratio Lower is generally better. Negative is bad. 0.09
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.91

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GNTA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 5.19
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Genenta Science SpA ADR share price today?

Genenta Science SpA ADR (GNTA) share price today is $4.8971

Can Indians buy Genenta Science SpA ADR shares?

Yes, Indians can buy shares of Genenta Science SpA ADR (GNTA) on Vested. To buy Genenta Science SpA ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GNTA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Genenta Science SpA ADR be purchased?

Yes, you can purchase fractional shares of Genenta Science SpA ADR (GNTA) via the Vested app. You can start investing in Genenta Science SpA ADR (GNTA) with a minimum investment of $1.

How to invest in Genenta Science SpA ADR shares from India?

You can invest in shares of Genenta Science SpA ADR (GNTA) via Vested in three simple steps:

  • Click on Sign Up or Invest in GNTA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Genenta Science SpA ADR shares
What is Genenta Science SpA ADR 52-week high and low stock price?

The 52-week high price of Genenta Science SpA ADR (GNTA) is $7.28. The 52-week low price of Genenta Science SpA ADR (GNTA) is $2.2.

What is Genenta Science SpA ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Genenta Science SpA ADR (GNTA) is

What is Genenta Science SpA ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Genenta Science SpA ADR (GNTA) is 5.19

What is Genenta Science SpA ADR dividend yield?

The dividend yield of Genenta Science SpA ADR (GNTA) is 0.00%

What is the Market Cap of Genenta Science SpA ADR?

The market capitalization of Genenta Science SpA ADR (GNTA) is $91.63M

What is Genenta Science SpA ADR’s stock symbol?

The stock symbol (or ticker) of Genenta Science SpA ADR is GNTA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top